发明授权
- 专利标题： Piperidinone carboxamide indane CGRP receptor antagonists
- 专利标题（中）： 哌啶酮甲酰胺二氢化茚CGRP受体拮抗剂
-
申请号： US13884632申请日： 2011-11-10
-
公开(公告)号： US08883807B2公开(公告)日： 2014-11-11
- 发明人: Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Cheng Wang , Blair C. Zartman , Heather E. Stevenson
- 申请人： Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Cheng Wang , Blair C. Zartman , Heather E. Stevenson
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 代理商 H. Eric Fischer; John C. Todaro
- 国际申请： PCT/US2011/060083 WO 20111110
- 国际公布： WO2012/064911 WO 20120518
- 主分类号： A01N43/90
- IPC分类号： A01N43/90 ; A61K31/519 ; A01N43/42 ; A61K31/44 ; C07D487/00 ; C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02 ; C07D515/02 ; A61K31/506 ; C07D471/04 ; C07D487/04
摘要：
The present invention is directed to piperidinone carboxamide indane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
公开/授权文献
信息查询
IPC分类:
